Pages that link to "Q33976842"
Jump to navigation
Jump to search
The following pages link to Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia (Q33976842):
Displaying 16 items.
- Epidemiology of invasive candidiasis: a persistent public health problem (Q29616758) (← links)
- Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards (Q30453651) (← links)
- International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia (Q30453797) (← links)
- Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel (Q33964932) (← links)
- Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest (Q33971002) (← links)
- Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi (Q33971884) (← links)
- Antifungal susceptibility testing: practical aspects and current challenges (Q33975757) (← links)
- E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method. (Q34193850) (← links)
- Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome (Q34510359) (← links)
- Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991). (Q34749364) (← links)
- Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program (Q37420953) (← links)
- Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients (Q37624691) (← links)
- Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species (Q39628247) (← links)
- Relationship between susceptibility of Candida spp. isolates to amphotericin B and death or survival of patients with candidemia episodes (Q46345548) (← links)
- Invitro antifungal susceptibilities of Candida species to liposomal amphotericin B, determined using CLSI broth microdilution, and amphotericin B deoxycholate, measured using the Etest (Q46446703) (← links)
- Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B (Q64070466) (← links)